Follow the Grace Therapeutics, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €44.6m. The latest transaction was reported on 10 September 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Kohli, Prashant. The full history is openly available.
12
Insider Decl.
n/a
Thresholds
€232,369
4 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Grace Therapeutics, Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$6.00.
33Σ signal
Buys €232,369n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.